Form F-3/A - Registration statement by foreign private issuers: [Amend]
SEC Accession No. 0001178913-23-003368
Filing Date
2023-10-23
Accepted
2023-10-23 16:06:05
Documents
7

Document Format Files

Seq Description Document Type Size
1 F-3/A zk2330395.htm F-3/A 394619
2 EXHIBIT 23.1 exhibit_23-1.htm EX-23.1 4515
3 image1.jpg GRAPHIC 1091
4 image2.jpg GRAPHIC 2251
5 image3.jpg GRAPHIC 1155
6 image00004.jpg GRAPHIC 62448
7 image00005.jpg GRAPHIC 106520
  Complete submission text file 0001178913-23-003368.txt   639388
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: F-3/A | Act: 33 | File No.: 333-274957 | Film No.: 231340064
SIC: 2834 Pharmaceutical Preparations